radiation-oncology

Documents about radiation-oncology

• Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer#911364ClinicalTrials.gov
• Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer#871278ClinicalTrials.gov
• Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer#839796ClinicalTrials.gov
• (P074) Patient-Reported Quality of Life Outcomes After De-Escalated Chemoradiation for HPV-Positive Oropharyngeal Carcinoma: Findings From a Phase II Trial#614736eScholarship
• Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction#810374ClinicalTrials.gov
• Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer#995190ClinicalTrials.gov
• Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis#810167ClinicalTrials.gov
• Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction#992390ClinicalTrials.gov
• Bone Remodeling after MR Imaging–guided High-Intensity Focused Ultrasound Ablation: Evaluation with MR Imaging, CT, Na18F-PET, and Histopathologic Examination in a Swine Model#683953eScholarship
• Image 3_Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management.tif#367121Figshare
• Image 4_Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management.tif#367122Figshare
• Image 1_Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management.tif#367123Figshare
• Image 2_Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management.tif#367124Figshare
• Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck#852967ClinicalTrials.gov
• Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival#851237ClinicalTrials.gov
• Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck#892819ClinicalTrials.gov
• Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer#854755ClinicalTrials.gov
• Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer#804902ClinicalTrials.gov
• RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer#851424ClinicalTrials.gov